KR900016262A - 포유류 중의 HIV-억제 항체 유도성 사람 면역 결핍 바이러스(HIV) env-암호화된 펩타이드 - Google Patents
포유류 중의 HIV-억제 항체 유도성 사람 면역 결핍 바이러스(HIV) env-암호화된 펩타이드Info
- Publication number
- KR900016262A KR900016262A KR1019890005480A KR890005480A KR900016262A KR 900016262 A KR900016262 A KR 900016262A KR 1019890005480 A KR1019890005480 A KR 1019890005480A KR 890005480 A KR890005480 A KR 890005480A KR 900016262 A KR900016262 A KR 900016262A
- Authority
- KR
- South Korea
- Prior art keywords
- hiv
- env
- mammals
- immunodeficiency virus
- human immunodeficiency
- Prior art date
Links
- 241000725303 Human immunodeficiency virus Species 0.000 title 3
- 241000124008 Mammalia Species 0.000 title 1
- 230000001939 inductive effect Effects 0.000 title 1
- 230000002401 inhibitory effect Effects 0.000 title 1
- 102000004196 processed proteins & peptides Human genes 0.000 title 1
- 108090000765 processed proteins & peptides Proteins 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
- C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
- C07K16/1036—Retroviridae, e.g. leukemia viruses
- C07K16/1045—Lentiviridae, e.g. HIV, FIV, SIV
- C07K16/1063—Lentiviridae, e.g. HIV, FIV, SIV env, e.g. gp41, gp110/120, gp160, V3, PND, CD4 binding site
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/16011—Human Immunodeficiency Virus, HIV
- C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
- C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Virology (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Immunology (AREA)
- Oncology (AREA)
- Gastroenterology & Hepatology (AREA)
- AIDS & HIV (AREA)
- Hematology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Communicable Diseases (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US18633388A | 1988-04-26 | 1988-04-26 | |
US186,333 | 1988-04-26 | ||
US324,027 | 1989-03-20 | ||
US07/324,027 US5562905A (en) | 1988-04-26 | 1989-03-20 | Human immunodeficiency virus (hiv) env-coded peptide capable of eliciting hiv-inhibiting antibodies in mammals |
Publications (2)
Publication Number | Publication Date |
---|---|
KR900016262A true KR900016262A (ko) | 1990-11-13 |
KR920001772B1 KR920001772B1 (ko) | 1992-03-02 |
Family
ID=22684532
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1019890005480A KR920001772B1 (ko) | 1988-04-26 | 1989-04-26 | 포유류 중의 HIV-억제 항체 유도성 사람 면역 결핍 바이러스(HIV) env-암호화된 펩타이드 |
Country Status (3)
Country | Link |
---|---|
US (1) | US5562905A (ko) |
KR (1) | KR920001772B1 (ko) |
ZA (1) | ZA893085B (ko) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5976541A (en) * | 1988-01-26 | 1999-11-02 | The United States Of America As Represented By The Department Of Health And Human Services | Potent peptide for stimulation of cytotoxic T lymphocytes specific for the HIV-1 envelope |
US5820865A (en) * | 1988-01-26 | 1998-10-13 | The United States Of America As Represented By The Department Of Health And Human Services | Method to induce cytotoxic T Lymphocytes specific for a broad array of HIV-1 isolates using hybrid synthetic peptides |
US20220056250A1 (en) | 2019-05-02 | 2022-02-24 | Dow Global Technologies Llc | Polyethylene-based compositions and films and articles comprising the same |
Family Cites Families (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3588248T2 (de) * | 1984-10-18 | 2004-07-01 | Institut Pasteur | LAV-Antigene und -Peptide |
US4629783A (en) * | 1985-04-29 | 1986-12-16 | Genetic Systems Corporation | Synthetic antigen for the detection of AIDS-related disease |
WO1987002775A1 (en) * | 1985-10-24 | 1987-05-07 | Southwest Foundation For Biomedical Research | Synthetic peptides and use for diagnosis and vaccination for aids and arc |
US5013543A (en) * | 1986-06-12 | 1991-05-07 | Revlon, Inc. | Cosmetic eyeliner formulation |
AU617088B2 (en) * | 1986-06-12 | 1991-11-21 | Biogen, Inc. | Peptides involved in the pathogenesis of hiv infection |
EP0276279A4 (en) * | 1986-07-21 | 1990-01-08 | Southwest Found Biomed Res | PREPARATION AND METHOD FOR IMMUNIZING AGAINST VIRAL AIDS AND ARC PATHOGENS. |
NZ221440A (en) * | 1986-08-20 | 1991-11-26 | Genetic Systems Corp | Composition containing monoclonal antibodies/peptides useful in treating and diagnosing hiv infections |
EP0273716B1 (en) * | 1986-12-30 | 1993-08-11 | THE UNITED STATES OF AMERICA as represented by the Secretary United States Department of Commerce | Synthetic peptides which induce cellular immunity to the aids virus and aids viral proteins |
WO1988009181A2 (en) * | 1987-05-29 | 1988-12-01 | Tanox Biosystems, Inc. | Monoclonal antibodies neutralizing hiv-1 |
IL87391A0 (en) * | 1987-08-27 | 1989-01-31 | Repligen Corp | Hiv proteins and peptides,dna coding therefor,vectors comprising such dna,the use of the proteins and peptides in diagnosis of aids and vaccine compositions containing them |
US5019387A (en) * | 1987-09-08 | 1991-05-28 | Duke University | Production of antibodies to HIV |
NL8702403A (nl) * | 1987-10-09 | 1989-05-01 | Stichting Centr Diergeneeskund | Oligopeptiden en gebruik daarvan voor diagnostische en vaccinatiedoeleinden voor aids en arc. |
EP0400076B1 (en) * | 1988-01-26 | 1996-05-15 | THE UNITED STATES OF AMERICA as represented by the Secretary United States Department of Commerce | A synthetic antigen evoking anti-hiv response |
CA1341285C (en) * | 1988-02-12 | 2001-08-14 | Chang Yi Wang | Synthetic peptides for the detection of antibodies to hiv gp120 envelope protein for diagnosis of aids and pre-aids conditions and as vaccines |
AU640619B2 (en) * | 1988-10-03 | 1993-09-02 | Repligen Corporation | Hiv proteins and peptides useful in the diagnosis, prophylaxis or therapy of aids |
-
1989
- 1989-03-20 US US07/324,027 patent/US5562905A/en not_active Expired - Lifetime
- 1989-04-26 KR KR1019890005480A patent/KR920001772B1/ko not_active IP Right Cessation
- 1989-04-26 ZA ZA893085A patent/ZA893085B/xx unknown
Also Published As
Publication number | Publication date |
---|---|
ZA893085B (en) | 1990-12-28 |
US5562905A (en) | 1996-10-08 |
KR920001772B1 (ko) | 1992-03-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATA257190A (de) | Virales polypeptid | |
AU3332089A (en) | Human immunodeficiency virus (hiv) env-coded peptide capable of eliciting hiv-inhibiting antibodies in mammals | |
FR2621487B1 (fr) | Virus avipox recombinant | |
DK603888D0 (da) | Rekombinant virus | |
NZ220653A (en) | Hiv env region peptides and d-retro versions thereof | |
DK517787A (da) | Lymphokinbeslaegtede peptider | |
DE68921923T2 (de) | Rekombinante Coccidiosis-Vakzine. | |
FR2620459B1 (fr) | Virus recombinant de la vaccine | |
NO921969D0 (no) | Ikke-replikerende rekombinant fremstilte retroviruspartikler brukt som antivirale midler og immunogener | |
LTIP335A (en) | Vaccine for human immunodeficiency virus | |
FR2669346B1 (fr) | Vaccin a poxvirus recombinant contre le virus de la rougeole. | |
DK354487A (da) | Oncogen-relaterede peptider | |
IT8821556A0 (it) | Peptidi immunostimolanti. | |
ITRM910546A0 (it) | Epitopi della proteina env del virus dell'epatite c | |
KR900700626A (ko) | 사람 면역결핍 바이러스-1 gp160으로부터 유도된 보호 펩티드 | |
KR900016262A (ko) | 포유류 중의 HIV-억제 항체 유도성 사람 면역 결핍 바이러스(HIV) env-암호화된 펩타이드 | |
NO177858C (no) | Peptid | |
ZA883878B (en) | Human immunodeficiency virus gag-encoded proteins | |
DK0498905T3 (da) | Tilpassede epitoper af human immundeficiensvirus kappeglycoprotein gp120 | |
KR900700509A (ko) | 인간 거대세포 바이러스의 면역원성 당단백질 | |
MC1830A1 (fr) | Peptides | |
KR890015935U (ko) | 절첩식 의자 | |
DE3990262T1 (de) | Rekombinante retroviren | |
PT85350A (de) | Xylometazolinhaltige pharmazeutische praeparate | |
DK258788D0 (da) | Peptidpraeparat |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
G160 | Decision to publish patent application | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant | ||
LAPS | Lapse due to unpaid annual fee |